Dupilumab Approved for Chronic Spontaneous Urticaria ...Middle East

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in patients ages 12 and older with CSU. Medscape Medical News

Hence then, the article about dupilumab approved for chronic spontaneous urticaria was published today ( Friday 18/04/2025 - 08:08 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Dupilumab Approved for Chronic Spontaneous Urticaria )

Also on site :

• “The Nation” Nominates Minneapolis for the Nobel Peace Prize
• Trump-Putin photo spotted at White House
• R&B Legend's Global Tour With Akon Announced